Faga Daniel's Form 4 filing
Anaptysbio, Inc (ANAB) · filed Jan 8, 2026
- Accession no.
- 0001673528-26-000004
- Filed
- Jan 8, 2026
- Trade date
- Jan 6-7, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market sales total $415.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Faga DanielCIK 0001673528 | Director, Officer (President, CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Common Stock | MOption exerciseAcquired | +17,850 | – | – | 475,989 | Direct | |
| Jan 7, 2026 | Common Stock | SSaleDisposed | −9,202 | $45.11 | −$415,102.22 | 466,787 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Common Stock | MOption exerciseDisposed | −17,850 | $0.00 | $0 | 17,850 | Direct | |
| Jan 6, 2026 | Common Stock | AGrant or awardAcquired | +98,600 | $0.00 | $0 | 98,600 | Direct | |
| Jan 6, 2026 | Common Stock | AGrant or awardAcquired | +133,400 | $0.00 | $0 | 133,400 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.